                         sequence LISTING

<110>  Illumina, Inc.
 
<120>  POLYNUCLEOTIDE AMPLIFICATION USING CRISPR-CAS SYSTEMS

<130>  12957-170-228

<140>  To be assigned
<141>  2015-11-10

<150>  62/078,355
<151>  2014-11-11

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  29
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Standard P5 sequence

<400>  1
aatgatacgg cgaccaccga gatctacac                                         29


<210>  2
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Standard P7 sequence

<400>  2
caagcagaag acggcatacg agat                                              24


<210>  3
<211>  32
<212>  DNA
<213>  Artificial sequence

<220>
<223>  PAM-Modified P5 sequence

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  n is a, c, g, or t

<400>  3
ccnaatgata cggcgaccac cgagatctac ac                                     32


<210>  4
<211>  27
<212>  DNA
<213>  Artificial sequence

<220>
<223>  PAM-Modified P7 sequence

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  n is a, c, g, or t

<400>  4
ccncaagcag aagacggcat acgagat                                           27


<210>  5
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Truncated PAM-Modified P5 sequence

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  n is a, c, g, or t

<400>  5
ccnaatgata cggcgaccac c                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Truncated PAM-Modified P7 sequence

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  n is a, c, g, or t

<400>  6
ccncaagcag aagacggcat a                                                 21


<210>  7
<211>  20
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Guide RNA P5 targeting

<400>  7
ucgguggucg ccguaucauu                                                   20


<210>  8
<211>  20
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Guide RNA P7 targeting

<400>  8
cguaugccgu cuucugcuug                                                   20


